Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme 1 selected

Guidance programme

Showing 1 to 4 of 4

TitleReference numberPublishedLast updated
Crizotinib for treating ROS1-positive advanced non-small-cell lung cancerTA1021
Brigatinib for treating ALK-positive advanced non-small-cell lung cancer after crizotinibTA571
Crizotinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancerTA422
Crizotinib for untreated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancerTA406

Results per page

  1. 10
  2. 25
  3. 50
  4. All